Sanjivani Paranteral Ltd.

About

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Sales	23.84	13.21	22.06	15.50	17.89	18.18	17.35	18.13	16.44	12.86	14.96
Expenses	19.67	11.64	18.22	13.25	15.25	15.57	14.80	15.28	14.10	10.70	12.99
Operating Profit	4.17	1.57	3.84	2.25	2.64	2.61	2.55	2.85	2.34	2.16	1.97
OPM %	17.49	11.88	17.41	14.52	14.76	14.36	14.70	15.72	14.23	16.80	13.17
Other Income	0.15	0.60	0.30	0.16	0.04	0.43	0.31	0.39	0.09	0.05	0.25
Depreciation	0.65	0.66	0.23	0.17	0.16	0.18	0.16	0.15	0.13	0.24	0.24
Interest	0.35	0.31	0.21	0.05	0.22	0.20	0.19	0.18	0.02	0.09	0.08
Profit before tax	3.32	1.20	3.70	2.19	2.30	2.66	2.51	2.91	2.28	1.88	1.90
Tax %	25.00	55.00	24.86	25.11	24.78	17.29	24.30	21.31	24.56	33.51	13.16
Net Profit	2.49	0.55	2.78	1.64	1.73	2.19	1.90	2.30	1.71	1.26	1.65
EPS in Rs	2.03	0.45	2.26	1.34	1.43	1.84	1.60	1.97	1.46	1.08	1.65

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024
Sales	68.67	70.10	54.41
Expenses	58.38	59.76	46.18
Operating Profit	10.29	10.34	8.23
OPM %	14.98	14.75	15.13
Other Income	0.97	1.22	0.52
Interest	0.65	0.59	0.25
Depreciation	1.22	0.62	0.93
Profit before tax	9.39	10.35	7.57
Tax %	28.75	21.84	18.63
Net Profit	6.69	8.09	6.17
EPS in Rs	5.45	6.81	5.28
Dividend Payout %	0.00	7.34	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Equity Capital	12.28	11.88	11.68
Reserves	35.96	26.11	16.22
Borrowings	14.28	8.14	0.97
Other Liabilities	25.46	32.07	14.53
Total Liabilities	87.98	78.20	43.40
Fixed Assets	47.34	20.64	9.94
CWIP	1.15	19.11	0.00
Investments	0.73	0.00	0.00
Other Assets	38.76	38.45	33.46
Total Assets	87.98	78.20	43.40

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Cash from Operating Activity	-0.11	12.40	-10.70
Cash from Investing Activity	-9.97	-21.91	-12.21
Cash from Financing Activity	9.84	10.46	23.16
Net Cash Flow	-0.24	0.94	0.24
Free Cash Flow	-10.18	-17.95	-14.00
CFO/OP %	20.00	133.00	-117.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Debtor Days	82.01	86.85	31.53
Inventory Days	91.17	94.77	124.70
Days Payable	30.61	137.51	73.56
Cash Conversion Cycle	142.57	44.11	82.67
Working Capital Days	45.98	-0.10	35.55
ROCE %	17.96	28.46	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	31.56	31.26	31.20	31.20	28.87	28.87	27.67	27.67	27.67	27.67	32.34	32.34
DIIs	5.45	6.03	6.03	6.02	6.15	6.15	6.26	6.26	9.36	9.71	6.01	8.16
Public	62.98	62.71	62.76	62.77	64.98	64.97	66.09	66.08	62.98	62.62	61.65	59.51
No. of Shareholders	5,880	5,933	6,017	6,286	6,429	6,447	6,618	6,731	6,166	4,911	4,500	4,500

Corporate Actions

7 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Dividend	19 Sep 2025	19 Sep 2025	—	0.50
Other	02 Sep 2013	—	—	—	General
Other	13 Sep 2012	—	—	—	General
Other	09 Sep 2010	—	—	—	General
Other	24 Aug 2009	—	—	—	General
Other	22 Sep 2008	—	—	—	General
Other	20 Sep 2007	—	—	—	General

Announcements

5 filings

Announcement under Regulation 30 (LODR)-Newspaper Publication
26 Aug 2026 26 Aug - Newspaper Advertisment of 32nd Annual general Meeting notice In accordance with Regulation 30 and Regulation 47 of the SEBI (LODR) Regulation, 2015.
Book Closure For AGM 24 Aug
24 Aug 2026
Notice Of AGM For 2025-26
24 Aug 2026 24 Aug - 32nd AGM on 16 September 2026 via VC/OAVM; books close 10-16 September; Ashwani Khemka reappointed by rotation.
Record Date For AGM 24 Aug
24 Aug 2026
Reg. 34 (1) Annual Report.
24 Aug 2026 24 Aug - Annual Report 2025-26 and AGM notice submitted to BSE on 24 Aug 2026.